@AlligatorBio profile picture
Alligator Bioscience @AlligatorBio

We are an innovative clinical-stage biotechnology company developing tumor-directed immunotherapies for the treatment of cancer.

Joined October 2017
  • Tweets 310
  • Following 50
  • Followers 390
87 Photos and videos
Alligator Bioscience retweeted
BioStock@BioStock_SWE
25 Oct 2022
Alligator Bioscience’s Q3 is out – comments from the CEO #LifeSciences #BioStockSwe @AlligatorBio biostock.se/en/2022/10/allig…
1
1
Alligator Bioscience retweeted
LifeSci Advisors@LifeSciAdvisors
16 Sep 2022
Tune into Episode 55 of the Benchtop Bios Podcast Series, featuring Søren Bregenholt, CEO of @AlligatorBio, who will discuss Alligator’s latest clinical data in the development of tumor-directed immunotherapies. Listen here: lifesci.events/AlligatorPod
1
Opportunity to join Alligator Bioscience! roirekrytering.se/lediga-job…
Alligator Bioscience AB reports H1 2022 and Q2 2022 financial results and provides a business update news.cision.com/alligator-bi…

Alligator Bioscience AB reports H1 2022 and Q2 2022 financial results and provides a business update

· Mitazalimab OPTIMIZE-1 interim data and ATOR-1017 Phase 1 on track to readout in H2 2022 ·

news.cision.com
1
Alligator Bioscience to Present Additional data of ATOR-1017 First-in-Human Study via poster presentation at ASCO Annual Meeting 2022 news.cision.com/alligator-bi…

Alligator Bioscience to Present Additional data of ATOR-1017 First-in-Human Study via poster...

· ATOR-1017 demonstrates an excellent clinical profile as a potential best-in-class 4-1BB

news.cision.com
1
6
Alligator Bioscience expands its Board of Directors with the appointment of Staffan Encrantz and Denise Goode news.cision.com/alligator-bi…

Alligator Bioscience expands its Board of Directors with the appointment of Staffan Encrantz and...

Lund, Sweden, May 9, 2022 - Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces the

news.cision.com
2
Bulletin from the annual general meeting in Alligator Bioscience AB on May 5, 2022 news.cision.com/alligator-bi…

Bulletin from the annual general meeting in Alligator Bioscience AB on May 5, 2022

The English text is an unofficial translation. In case of any discrepancies between the Swedish

news.cision.com
1
Alligator Bioscience AB: Interim report January–March 2022 news.cision.com/alligator-bi…
2
Invitation to the Presentation of Alligator Bioscience´s Interim Report January - March 2022 on April 27, 2022 news.cision.com/alligator-bi…

Invitation to the Presentation of Alligator Bioscience´s Interim Report January - March 2022 on...

LUND (Sweden) – April 22, 2022 – Alligator Bioscience will host a conference call (in English)

news.cision.com
1
Notice of annual general meeting in Alligator Bioscience AB news.cision.com/alligator-bi…

Notice of annual general meeting in Alligator Bioscience AB

The English text is an unofficial translation. In case of any discrepancies between the Swedish

news.cision.com
1
Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences news.cision.com/alligator-bi…

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and...

Lund, Sweden, April 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the

news.cision.com
3
Change in number of shares and votes in Alligator Bioscience AB news.cision.com/alligator-bi…

Change in number of shares and votes in Alligator Bioscience AB

During the month of March, the number of shares and votes in Alligator Bioscience AB have

news.cision.com
Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg news.cision.com/alligator-bi…

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase...

Lund, Sweden, March 23, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an

news.cision.com
6
Issue and repurchase of series C shares for performance-based share saving program news.cision.com/alligator-bi…

Issue and repurchase of series C shares for performance-based share saving program

Pursuant to the authorization granted by the annual general meeting on 1 June 2021, the board of

news.cision.com
Alligator Bioscience publishes Annual Report for 2021 news.cision.com/alligator-bi…

Alligator Bioscience publishes Annual Report for 2021

Lund, Sweden, March 22, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced

news.cision.com
Nomination Committee’s proposal ahead of the AGM 2022 in Alligator Bioscience AB
1
Invitation to the Presentation of Alligator Bioscience´s Year-End Report January - December 2021 on February 11, 2022 news.cision.com/alligator-bi…

Invitation to the Presentation of Alligator Bioscience´s Year-End Report January - December 2021 on...

LUND (Sweden) – February 4, 2022 – Alligator Bioscience will host a conference call (in English)

news.cision.com
1
Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer news.cision.com/alligator-bi…

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Lund, Sweden, February 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator

news.cision.com
1
1
Nomination Committee Appointed in Respect of AGM 2022 in Alligator Bioscience AB news.cision.com/alligator-bi…

Nomination Committee Appointed in Respect of AGM 2022 in Alligator Bioscience AB

Lund, Sweden, January 20, 2021– Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator

news.cision.com
1
Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty news.cision.com/alligator-bi…

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University...

Lund, Sweden, January 19, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced

news.cision.com
5
Load more